EVALUATION OF MACULAR FLOW VOIDS ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY AS POTENTIAL BIOMARKERS FOR SILENT CEREBRAL INFARCTION IN SICKLE CELL DISEASE.

MLA

Thangamathesvaran, Loka, et al. “Evaluation of Macular Flow Voids on Optical Coherence Tomography Angiography as Potential Biomarkers for Silent Cerebral Infarction in Sickle Cell Disease.” Retina (Philadelphia, Pa.), vol. 42, no. 2, Feb. 2022, pp. 340–47. EBSCOhost, https://doi.org/10.1097/IAE.0000000000003309.

APA

Thangamathesvaran, L., Ong, S. S., Wang, J., Lance, E., Tekes, A., & Scott, A. W. (2022). Evaluation of Macular Flow Voids on Optical Coherence Tomography Angiography as Potential Biomarkers for Silent Cerebral Infarction in Sickle Cell Disease. Retina (Philadelphia, Pa.), 42(2), 340–347. https://doi.org/10.1097/IAE.0000000000003309

Chicago

Thangamathesvaran, Loka, Sally S Ong, Jiangxia Wang, Eboni Lance, Aylin Tekes, and Adrienne W Scott. 2022. “Evaluation of Macular Flow Voids on Optical Coherence Tomography Angiography as Potential Biomarkers for Silent Cerebral Infarction in Sickle Cell Disease.” Retina (Philadelphia, Pa.) 42 (2): 340–47. doi:10.1097/IAE.0000000000003309.